NCT07912710Toboroz
China HEalthy Aging and Dementia Study (HEAD)
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. nov. 3.
Rövid összefoglaló (regiszter, angolul)
The China HEalthy Aging and Dementia (HEAD) study is a large-scale, community-based, multi-center prospective cohort study covering eastern, northern, southern, and central-western regions of China. By integrating comprehensive clinical, neuroimaging, biospecimen, and multi-omics data, the study aims to advance the early prediction and diagnosis of Alzheimer's disease and related dementias (ADRD) and provide a foundation for future intervention studies in the Chinese population. The primary aims of the China HEAD study are as follows: 1. To establish a community-based prospective cohort by recruiting over 20,000 participants from eastern, northern, southern, western, and middle regions of China. 2. To build a comprehensive biobank by collecting demographic information, disease history, cognitive function, physical measures, electrophysiologic data, multimodal imaging data, as well as biospecimens and derived multi-omics data. 3. To conduct early prediction and diagnosis studies for ADRD and support future intervention studies based on the above-mentioned cohort and biobank.
- Állapot (regiszter)
- Toboroz
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 20000 (tervezett)
- Első benyújtás
- 2026. okt. 19.
- Kezdés
- 2022. aug. 1.
- Elsődleges befejezés
- 2072. aug. 1.
- Fő szponzor
- Fudan University
- Betegségek
- Alzheimer-kór
- NCT-szám
- NCT07912710
Mit vállalsz
- Vizsgálat típusa: Megfigyeléses
- Tervezett résztvevők: 20000
- 2022. aug. 1. és az elsődleges befejezés (2072. aug. 1.) között
- 30 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Más betegség
- Self-reported stroke events (e.g., cerebral hemorrhage or cerebral infarction) within the past six months.
- Self-reported diseases potentially impairing cognition, including congenital intellectual disability, intracranial tumors, epilepsy, Parkinson's disease, or severe psychiatric disorders such as schizophrenia requiring medication.
- Self-reported major organ failure (e.g., liver or kidney failure), malignancy, or other conditions associated with a shortened life expectancy that prevent completion of follow-up assessments.
- Additional exclusion criteria for participants undergoing magnetic resonance imaging (MRI):
- Inability to tolerate MRI examinations or contraindications to MRI, including claustrophobia; MRI-incompatible implanted pacemakers, aneurysm clips, artificial heart valves, cochlear implants, or other metallic implants; or other clinical conditions or examination findings that investigators consider potentially harmful during MRI.
Egyéb
- The following exclusion criteria apply to participants in the HEAD study:
- Refusal to provide written informed consent.
- Refusal to participate in questionnaires or other data collection procedures.
- Refusal to provide blood or other biological samples.
Kiket keres a vizsgálat
- China HEAD Community Cohort:
- Resident in a Chinese community.
- Aged 50-79 years.
- Have adequate vision and hearing (with glasses or hearing aids if necessary), and be able to walk, communicate, and complete study-related assessments (including questionnaires, physical examinations, neuropsychological assessments, and biospecimen collection) independently or with assistance.
- Willing to provide written informed consent for baseline assessments, follow-up, biospecimen donation, and data collection.
- China HEAD Familial Sub-cohort:
- Resident in a Chinese community.
- Aged 18 years or older.
- Have a family history of Alzheimer's disease (AD) involving at least two first-degree relatives across at least two consecutive generations, with AD diagnoses previously established at tertiary hospitals and verified through medical history.
- Meet the 2011 National Institute on Aging-Alzheimer's Association (NIA-AA) diagnostic criteria for AD.
- Have adequate vision and hearing (with glasses or hearing aids if necessary), and be able to walk, communicate, and complete study-related assessments (including questionnaires, physical examinations, neuropsychological assessments, and biospecimen collection) independently or with assistance.
- Willing to provide written informed consent for baseline assessments, follow-up, biospecimen donation, and data collection.
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket is fogad
Helyszínek (30)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Peking University | Beijing | Kína | Toboroz |
| Chinese PLA General Hospital | Beijing | Kína | Toboroz |
| Xuanwu Hospital, Capital Medical University | Beijing | Kína | Toboroz |
| Beijing Tiantan Hospital,Capital Medical University | Beijing | Kína | Toboroz |
| Beijing Normal University | Beijing | Kína | Toboroz |
| Beijing University of Posts and Telecommunications | Beijing | Kína | Toboroz |
| Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences | Beijing | Kína | Toboroz |
| Peking Union Medical College Hospital | Beijing | Kína | Toboroz |
| Jilin University | Changchun | Kína | Toboroz |
| Sichuan University | Chengdu | Kína | Toboroz |
| Army Medical University, China | Chongqing | Kína | Toboroz |
| Fujian Medical University | Fuzhou | Kína | Toboroz |
| Southern Medical University | Guangzhou | Kína | Toboroz |
| Sun Yat-sen University | Guangzhou | Kína | Toboroz |
| The First Affiliated Hospital of University of Science and Technology of China | Hefei | Kína | Toboroz |
| Shandong First Medical University | Jinan | Kína | Toboroz |
| Southeast University, China | Nanjing | Kína | Toboroz |
| Qingdao University | Qingdao | Kína | Toboroz |
| Ruijin Hospital Shanghai Jiaotong University School of Medicine | Shanghai | Kína | Toboroz |
| Shanghai University | Shanghai | Kína | Toboroz |
| Fudan University | Shanghai | Kína | Toboroz |
| Tongji University | Shanghai | Kína | Toboroz |
| Shenzhen University | Shenzhen | Kína | Toboroz |
| Shenzhen Bay Laboratory | Shenzhen | Kína | Toboroz |
| Fudan University Taizhou Institute of Health Sciences | Taizhou | Kína | Toboroz |
| Tianjin Medical University | Tianjin | Kína | Toboroz |
| Wuhan University of Science and Technology | Wuhan | Kína | Toboroz |
| The First Affiliated hospital of Xiamen University | Xiamen | Kína | Toboroz |
| Qinghai Provincial People's Hospital | Xining | Kína | Toboroz |
| Zhoukou Central Hospital | Zhoukou | Kína | Toboroz |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.